Went Gregory T

CIK 00016045411 companyEMERYVILLE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001604541

Recent Transactions

50 trades

Award
Adamas Pharmaceuticals Inc
Common Stock
2019-04-08+56,250→ 232,541 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2019-04-08+112,500→ 112,500 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2019-03-20$7.99/sh−6,319→ 176,291 total
Purchase
Adamas Pharmaceuticals Inc
Common Stock
2018-11-07$12.98/sh+3,850→ 199,242 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2018-03-21$25.75/sh−4,541→ 182,610 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2018-03-06+123,750→ 123,750 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2018-03-06+20,625→ 187,151 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2017-03-21$17.03/sh−2,807→ 166,526 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2017-02-21+23,125→ 169,333 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2017-02-21+138,750→ 138,750 total
Other
Adamas Pharmaceuticals Inc
Common Stock
2016-10-05−195,400→ 195,392 total
Other
Adamas Pharmaceuticals Inc
Common Stock
2016-10-05−117,450→ 146,208 total
Other
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2016-10-05−121,784→ 128,216 total
Other
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2016-10-05−27,995→ 32,005 total
Other
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2016-10-05−262,963→ 605,037 total
Other
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2016-10-05−9,439→ 65,561 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Common Stock
2016-06-15$1.88/sh+204,900→ 263,658 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2016-06-15−204,900→ 0 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Common Stock
2016-06-15$1.88/sh+204,900→ 263,658 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2016-03-04$13.66/sh+28,750→ 58,758 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2016-03-04+172,500→ 172,500 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2015-05-14$18.00/sh−100→ 30,008 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2015-05-14−100→ 214,900 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2015-05-14$18.00/sh−200→ 390,792 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Common Stock
2015-05-14$1.88/sh+100→ 30,108 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2015-05-13−10,028→ 215,000 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2015-05-13$18.00/sh−100→ 390,992 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2015-05-13$18.00/sh−28→ 30,008 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Common Stock
2015-05-13$1.88/sh+10,028→ 30,036 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Common Stock
2015-05-12$1.88/sh+500→ 20,508 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2015-05-12$18.01/sh−500→ 20,008 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2015-05-12−500→ 225,028 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2015-05-12$18.00/sh−1,800→ 391,092 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2015-04-23−900→ 225,528 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2015-04-23$18.00/sh−2,400→ 392,892 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Common Stock
2015-04-23$1.88/sh+900→ 20,908 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2015-04-23$18.00/sh−900→ 20,008 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Common Stock
2015-04-21$1.88/sh+962→ 20,970 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2015-04-21$18.00/sh−1,811→ 395,292 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2015-04-21−962→ 226,428 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2015-04-21$18.01/sh−962→ 20,008 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2015-04-20−2,610→ 227,390 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2015-04-20$18.00/sh−2,610→ 20,008 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2015-04-20$18.00/sh−5,200→ 397,103 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Common Stock
2015-04-20$1.88/sh+2,610→ 22,618 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Common Stock
2015-04-14$1.88/sh+80→ 10,088 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2015-04-14$1.88/sh+10,000→ 20,008 total
Sale
Adamas Pharmaceuticals Inc
Common Stock
2015-04-14$18.00/sh−100→ 402,303 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2015-04-14−10,000→ 220,000 total
Exercise/Conversion
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2015-04-14−80→ 230,000 total

Companies

Adamas Pharmaceuticals Inc
Director, Chief Executive Officer, 10% Owner

Recent Filings

Address

C/O ADAMAS PHARMACEUTICALS, INC. 2200 POWELL ST, STE 220

EMERYVILLE, CA, 94608

View on SEC.gov